Solgenics Ltd (AIM:SGN), the company formerly known as Ncondezi Energy, has today announced plans to leave AIM and delist.
The company, in a statement, said continuing its listing is unlikely to provide the company with significantly wider or more cost-effective access to capital than the funding options it already has from majority shareholders in the near to mid-term.
Light Science Technologies Holdings PLC (AIM:LST) said its revenues grew by 10.5% to £8.17mln in the year ended November 30, 2022, boosted by record sales in its contract electronics manufacturing (CEM) division.
The company, which specialises in controlled environment agriculture (CEA) technology, also highlighted progress in the CEA division, including the UKRI grant-supported advanceGROW rolling cloche and the launch of sensorGROW MVP version.
OKYO Pharma Ltd (LSE:OKYO, NASDAQ:OKYO), an ophthalmology-focused biopharmaceutical company, will showcase two presentations on its dry eye disease (DED) treatment, OK-101, at the American Society of Cataract and Refractive Surgery (ASCRS 2023) in San Diego, California, from 5-8 May.
Dr Pedram Hamrah, a leading expert on Neuropathic Corneal Pain (NCP) and DED, will present both papers at the conference.